The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab plus anlotinib and chemotherapy as first-line treatment for advanced malignant pleural mesothelioma (SACH-MPM): A prospective, single-arm, phase II trial.
 
Yiyi Huang
No Relationships to Disclose
 
Xinyu Wu
No Relationships to Disclose
 
Xiaohui Ren
No Relationships to Disclose
 
Xianzhen Wu
No Relationships to Disclose
 
Rui Wan
No Relationships to Disclose
 
Kailun Fei
No Relationships to Disclose
 
Boyang Sun
No Relationships to Disclose
 
Jiachen Xu
No Relationships to Disclose
 
Jia Zhong
No Relationships to Disclose
 
Zhijie Wang
No Relationships to Disclose
 
Lin Wang
No Relationships to Disclose
 
Binbin Shan
No Relationships to Disclose
 
Qinxiang Guo
No Relationships to Disclose
 
Jie Wang
No Relationships to Disclose
 
Jianchun Duan
No Relationships to Disclose